Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
1. Aftate
2. Breezee
3. Chinofungin
4. Chlorisept
5. Curatin
6. Genaspor
7. Micoisdin
8. Np 27
9. Np-27
10. Np27
11. Ony Clear
12. Ony-clear
13. Purder N, Tolnaftat
14. Sporiline
15. Tinactin
16. Tinaderm
17. Tinatox
18. Tineafax
19. Ting
20. Tolnaftat Purder N
21. Tolnaftate
22. Tonoftal
23. Zeasorb
1. 557-08-4
2. Zinc 10-undecenoate
3. Zinc;undec-10-enoate
4. Zinc Diundec-10-enoate
5. 10-undecenoic Acid Zinc Salt
6. 10-undecenoic Acid, Zinc Salt
7. 10-undecenoic Acid (zinc Salt)
8. 388vz25dur
9. 10-undecenoic Acid Zinc
10. Undesine
11. 10-undecenoic Acid, Zinc (2+) Salt
12. 10-undecenoic Acid, Zinc Salt (2:1)
13. Mycoseptin
14. Zinc Undec-10-enoate
15. Tineafax
16. Hongo Cura
17. Undecylenic Acid Zinc Salt
18. Mfcd00067246
19. Nsc-402438
20. Unii-388vz25dur
21. Zinc Undecylenate [usp:jan]
22. Einecs 209-155-0
23. Nsc 402438
24. 10-undecenoicacidzinc
25. Undecylenate Zinc
26. Zinc Undecylenate (tn)
27. Schembl160840
28. Zinc Undecylenate (jan/usp)
29. Zinc Undecylenate [jan]
30. Zinc Undecylenate [inci]
31. Chebi:32313
32. Hy-b0914a
33. Dtxsid90890497
34. Undecylenate Zinc [vandf]
35. Zinc Undecenoate [mart.]
36. Zinc Undecylenate [vandf]
37. Hms2093l19
38. Pharmakon1600-01505467
39. Zinc Undecylenate [who-dd]
40. Nsc759140
41. Akos026749938
42. Ccg-269028
43. Cs-4809
44. Nsc-759140
45. Undecylenic Acid Zinc Salt [mi]
46. Zinc Undecylenate [ep Monograph]
47. Zinc Undecylenate [usp Monograph]
48. Ft-0689090
49. D01124
50. Q27256764
| Molecular Weight | 431.9 g/mol |
|---|---|
| Molecular Formula | C22H38O4Zn |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 16 |
| Exact Mass | 430.206151 g/mol |
| Monoisotopic Mass | 430.206151 g/mol |
| Topological Polar Surface Area | 80.3 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 136 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Antifungal Agents
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dr. Paul Lohmann GmbH & Co. KGaA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Avesta Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Esteem Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gloria Interchem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Neelkanth MineChem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Topical
Solubilizers
Emulsifying Agents
Thickeners and Stabilizers
Parenteral
Lubricants & Glidants
Film Formers & Plasticizers
Surfactant & Foaming Agents
Fillers, Diluents & Binders
Controlled & Modified Release
Coating Systems & Additives
Market Place
ABOUT THIS PAGE
82
PharmaCompass offers a list of Zinc Undecylenate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zinc Undecylenate manufacturer or Zinc Undecylenate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zinc Undecylenate manufacturer or Zinc Undecylenate supplier.
PharmaCompass also assists you with knowing the Zinc Undecylenate API Price utilized in the formulation of products. Zinc Undecylenate API Price is not always fixed or binding as the Zinc Undecylenate Price is obtained through a variety of data sources. The Zinc Undecylenate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A EINECS 209-155-0 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of EINECS 209-155-0, including repackagers and relabelers. The FDA regulates EINECS 209-155-0 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. EINECS 209-155-0 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of EINECS 209-155-0 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A EINECS 209-155-0 supplier is an individual or a company that provides EINECS 209-155-0 active pharmaceutical ingredient (API) or EINECS 209-155-0 finished formulations upon request. The EINECS 209-155-0 suppliers may include EINECS 209-155-0 API manufacturers, exporters, distributors and traders.
click here to find a list of EINECS 209-155-0 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A EINECS 209-155-0 DMF (Drug Master File) is a document detailing the whole manufacturing process of EINECS 209-155-0 active pharmaceutical ingredient (API) in detail. Different forms of EINECS 209-155-0 DMFs exist exist since differing nations have different regulations, such as EINECS 209-155-0 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A EINECS 209-155-0 DMF submitted to regulatory agencies in the US is known as a USDMF. EINECS 209-155-0 USDMF includes data on EINECS 209-155-0's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The EINECS 209-155-0 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of EINECS 209-155-0 suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing EINECS 209-155-0 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for EINECS 209-155-0 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture EINECS 209-155-0 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain EINECS 209-155-0 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a EINECS 209-155-0 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of EINECS 209-155-0 suppliers with NDC on PharmaCompass.
EINECS 209-155-0 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of EINECS 209-155-0 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right EINECS 209-155-0 GMP manufacturer or EINECS 209-155-0 GMP API supplier for your needs.
A EINECS 209-155-0 CoA (Certificate of Analysis) is a formal document that attests to EINECS 209-155-0's compliance with EINECS 209-155-0 specifications and serves as a tool for batch-level quality control.
EINECS 209-155-0 CoA mostly includes findings from lab analyses of a specific batch. For each EINECS 209-155-0 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
EINECS 209-155-0 may be tested according to a variety of international standards, such as European Pharmacopoeia (EINECS 209-155-0 EP), EINECS 209-155-0 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (EINECS 209-155-0 USP).
